Literature DB >> 25983657

Comparison of a restrictive versus liberal red cell transfusion policy for patients with myelodysplasia, aplastic anaemia, and other congenital bone marrow failure disorders.

Yisu Gu1, Lise J Estcourt2, Carolyn Doree3, Marialena Trivella4, Sally Hopewell4, Paresh Vyas5.   

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the efficacy and safety of a restrictive versus liberal red cell transfusion strategy for patients with long-term bone marrow failure. These include myelodysplasia, acquired aplastic anaemia, and other inherited bone marrow failure disorders.

Entities:  

Year:  2015        PMID： 25983657      PMCID： PMC4430822          DOI： 10.1002/14651858.CD011577

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN： 1361-6137


  32 in total

1.  Selection of patients for bone marrow transplantation in severe aplastic anemia.

Authors:  B M Camitta; J M Rappeport; R Parkman; D G Nathan
Journal:  Blood       Date:  1975-03       Impact factor: 22.113

Review 2.  The case of the misleading funnel plot.

Authors:  Joseph Lau; John P A Ioannidis; Norma Terrin; Christopher H Schmid; Ingram Olkin
Journal:  BMJ       Date:  2006-09-16

Review 3.  Nonsurgical bleeding diathesis in anemic thrombocytopenic patients: role of temperature, red blood cells, platelets, and plasma-clotting proteins.

Authors:  C Robert Valeri; Shukri Khuri; Gina Ragno
Journal:  Transfusion       Date:  2007-10       Impact factor: 3.157

4.  Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making.

Authors:  Luca Malcovati; Matteo Giovanni Della Porta; Cristiana Pascutto; Rosangela Invernizzi; Marina Boni; Erica Travaglino; Francesco Passamonti; Luca Arcaini; Margherita Maffioli; Paolo Bernasconi; Mario Lazzarino; Mario Cazzola
Journal:  J Clin Oncol       Date:  2005-09-26       Impact factor: 44.544

5.  The epidemiology of aplastic anemia in Thailand.

Authors:  Surapol Issaragrisil; David W Kaufman; Theresa Anderson; Kanchana Chansung; Paul E Leaverton; Samuel Shapiro; Neal S Young
Journal:  Blood       Date:  2005-10-27       Impact factor: 22.113

6.  A multicenter pilot-randomized controlled trial of the feasibility of an augmented red blood cell transfusion strategy for patients treated with induction chemotherapy for acute leukemia or stem cell transplantation.

Authors:  Kathryn E Webert; Richard J Cook; Stephen Couban; Julie Carruthers; Ker-Ai Lee; Morris A Blajchman; Jeffrey H Lipton; Joseph M Brandwein; Nancy M Heddle
Journal:  Transfusion       Date:  2007-09-24       Impact factor: 3.157

7.  The role of occupational and environmental exposures in the aetiology of acquired severe aplastic anaemia: a case control investigation.

Authors:  K R Muir; C E D Chilvers; C Harriss; L Coulson; M Grainge; P Darbyshire; C Geary; J Hows; J Marsh; T Rutherford; M Taylor; E C Gordon-Smith
Journal:  Br J Haematol       Date:  2003-12       Impact factor: 6.998

Review 8.  Anemia as a risk factor for cardiovascular disease.

Authors:  Arema A Pereira; Mark J Sarnak
Journal:  Kidney Int Suppl       Date:  2003-11       Impact factor: 10.545

9.  Myelodysplastic syndromes: incidence and survival in the United States.

Authors:  Xiaomei Ma; Monique Does; Azra Raza; Susan T Mayne
Journal:  Cancer       Date:  2007-04-15       Impact factor: 6.860

10.  Practical methods for incorporating summary time-to-event data into meta-analysis.

Authors:  Jayne F Tierney; Lesley A Stewart; Davina Ghersi; Sarah Burdett; Matthew R Sydes
Journal:  Trials       Date:  2007-06-07       Impact factor: 2.279
View more
  4 in total

Review 1.  Comparison of a restrictive versus liberal red cell transfusion policy for patients with myelodysplasia, aplastic anaemia, and other congenital bone marrow failure disorders.

Authors:  Yisu Gu; Lise J Estcourt; Carolyn Doree; Sally Hopewell; Paresh Vyas
Journal:  Cochrane Database Syst Rev       Date:  2015-10-05

Review 2.  Red blood cell storage time and transfusion: current practice, concerns and future perspectives.

Authors:  María García-Roa; María Del Carmen Vicente-Ayuso; Alejandro M Bobes; Alexandra C Pedraza; Ataúlfo González-Fernández; María Paz Martín; Isabel Sáez; Jerard Seghatchian; Laura Gutiérrez
Journal:  Blood Transfus       Date:  2017-05       Impact factor: 3.443

3.  Measuring the impact of ambulatory red blood cell transfusion on home functional status: study protocol for a pilot randomized controlled trial.

Authors:  Dennis H Murphree; Theresa N Kinard; Nandita Khera; Curtis B Storlie; Che Ngufor; Sudhindra Upadhyaya; Jyotishman Pathak; Emma Fortune; Eapen K Jacob; Rickey E Carter; Karl A Poterack; Daryl J Kor
Journal:  Trials       Date:  2017-03-31       Impact factor: 2.279

4.  Prognostic Significance of Blood Transfusion in Newly Diagnosed Multiple Myeloma Patients without Autologous Hematopoietic Stem Cell Transplantation.

Authors:  Liping Fan; Danhui Fu; Jinping Zhang; Haobo Huang; Qingqing Wang; Yamei Ye; Qianling Xie
Journal:  Biomed Res Int       Date:  2017-05-08       Impact factor: 3.411
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.